| Literature DB >> 23619194 |
Abstract
Diabetic nephropathy (DN) is the most common cause of chronic kidney disease (CKD) and its number has been increasing. CKD is a worldwide threat to health but the precise mechanism of this problem is not fully appreciated. It is believed that hyperglycemia is one of the most important metabolic factors in the development of DN. Multiple molecular mechanisms have been proposed to mediate hyperglycemia's adverse effects on kidney. To identify targets for therapeutic intervention, most studies have focused on understanding how abnormal levels of such metabolities cause DN. However, there have been few reports regarding endogenous renal protective factors. Thus, recognition of the importance of this could be providing a new perspective for understanding the development of DN and a new therapeutic paradigm to combat DN.Entities:
Keywords: Angiopoietins; Diabetic nephropathy (DN); Dipeptidyl peptidase-4 (DPP-4) inhibitors; Endostatin; Glucagon like peptide-1 (GLP-1); Insulin; Insulin receptor substrate 1 (IRS1); Protein kinase C (PKC); Src homology-2 domain containing phosphatase-1 (SHP-1); Tumstatin; Vascular endothelial growth factor (VEGF)
Mesh:
Substances:
Year: 2013 PMID: 23619194 DOI: 10.1016/j.jdiacomp.2013.03.003
Source DB: PubMed Journal: J Diabetes Complications ISSN: 1056-8727 Impact factor: 2.852